Food and Drug Administration (FDA)
Although the 5th Circuit Court’s decision does not go as far as anti-abortion advocates might have hoped, it is still a grave threat to abortion access.
OPill is the first over-the-counter birth control pill available in the U.S. It is safe, effective, and will increase access to contraception for millions of women nationwide.
Read the NWHN’s testimony to the FDA in support of OPILL, an oral contraceptive, being approved for over-the-counter dispensation.
The National Women’s Health Network applauds the Supreme Court for its decision to block the lower court’s ruling against Mifepristone, one of two medication abortion drugs, until the end of the legal proceedings.
Patients are turning to telehealth appointments and online pharmacies for routine medical care during the COVID-19 outbreak without having to leave their homes. But for most pregnant people seeking safe and effective abortion pills, the FDA has created a Byzantine set of rules that delay or block access to care.
This Wednesday, the Senate Committee on Health, Education, Labor and Pensions (HELP) will consider the nomination of Dr. Scott Gottlieb to head the Food and Drug Administration (FDA).